Prescription Opioid Exposures Among Children and Adolescents in the United States: 2000-2015

Summary/Excerpts

Prescription opioid-related HCF admissions and serious medical outcomes were higher among teenagers. Contrary to trends for other prescription opioids, exposures to buprenorphine have increased in recent years; children aged 0 to 5 years accounted for almost 90% of buprenorphine exposures. These findings indicate that additional prevention efforts are needed.

Key Statistics

The rate of prescription opioid-related suspected suicides among teenagers increased by 52.7% during [2000 through 2015]

Children aged 0 to 5 years accounted for almost 90% of buprenorphine exposures.

Citation

Allen J, Casavant M, Spiller H, Chounthirath T, Hodges N, Smith G. Prescription opioid exposures among children and adolescents in the US: 2000-2015. Pediatrics. 2017;139(4):e20163382.

About

Medication Safety Made Simple empowers communities through education and advocacy to enhance medication best practices, save lives, and foster healthier communities.

Important Pages

Join our Email Newsletter

Please enable JavaScript in your browser to complete this form.
What do you want to hear about?

© MedicationSafetyMadeSimple.com – All rights reserved.